KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Boston Scientific (BSX) over the last 16 years, with Q4 2025 value amounting to $342.0 million.

  • Boston Scientific's Other Operating Expenses fell 86.96% to $342.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 1297.17%. This contributed to the annual value of $1.1 billion for FY2025, which is N/A changed from last year.
  • Per Boston Scientific's latest filing, its Other Operating Expenses stood at $342.0 million for Q4 2025, which was down 86.96% from $247.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Other Operating Expenses high stood at $500.0 million for Q2 2024, and its period low was -$22.0 million during Q4 2022.
  • Its 5-year average for Other Operating Expenses is $203.4 million, with a median of $240.0 million in 2024.
  • Per our database at Business Quant, Boston Scientific's Other Operating Expenses plummeted by 17333.33% in 2022 and then surged by 125000.0% in 2023.
  • Quarter analysis of 5 years shows Boston Scientific's Other Operating Expenses stood at $30.0 million in 2021, then plummeted by 173.33% to -$22.0 million in 2022, then skyrocketed by 1250.0% to $253.0 million in 2023, then skyrocketed by 36.36% to $345.0 million in 2024, then fell by 0.87% to $342.0 million in 2025.
  • Its Other Operating Expenses was $342.0 million in Q4 2025, compared to $247.0 million in Q3 2025 and $280.0 million in Q2 2025.